Green Cross Corporation Logo

Green Cross Corporation

006280.KS

(2.0)
Stock Price

162.300,00 KRW

-0.28% ROA

-1.86% ROE

-176.25x PER

Market Cap.

1.306.804.530.000,00 KRW

0% DER

1.53% Yield

-1.48% NPM

Green Cross Corporation Stock Analysis

Green Cross Corporation Fundamental Analysis

Fundamental analysis in stock investing is like studying the foundation of a house before buying it. It involves looking at a company's financial health, like its earnings, assets, and debts, to determine if it's a good investment based on its fundamental strength and potential for growth.

Green Cross Corporation Fundamental Stock Analysis
# Analysis Rating
1 Revenue Growth

With a track record of consistent revenue growth in the past five years, this company presents a compelling opportunity.

2 Assets Growth

With a track record of consistent revenue growth in the past five years, this company presents a compelling opportunity.

3 ROE

The stock's ROE falls within an average range (1.24%), demonstrating satisfactory profitability and efficiency in utilizing shareholders' equity.

4 ROA

The stock's ROA (1.7%) shows that it's doing a pretty good job at making money from its assets, making it a solid choice to invest and earn steady profits.

5 PBV

The stock's PBV ratio (1.03x) indicates a justifiable valuation, presenting a compelling choice for investors seeking reasonable returns.

6 DER

The stock has a reasonable amount of debt compared to its ownership (53%), suggesting a balanced financial position and a moderate level of risk.

7 Net Profit Growth

This company's net profit has remained flat over the past five years, suggesting a lack of growth and making it a less attractive investment opportunity.

8 Graham Number

The company's Graham number indicates that it is overvalued compared to its stock price, suggesting a potentially unfavorable investment opportunity.

9 Dividend Growth

The company's dividend growth has remained unchanged for three years, signaling a lack of positive momentum and making it a less favorable investment choice.

10 Dividend

Investors should note the absence of dividends from the company in the last three years, indicating potential financial challenges.

11 Buffet Intrinsic Value

Warren Buffett's formula suggests that the company's stock is overpriced (-14.779.416), presenting a possible disadvantage for investors as its market price surpasses its estimated intrinsic value.

Green Cross Corporation Technical Analysis

Technical analysis in stock investing is like reading the patterns on a weather map to predict future weather conditions. It involves studying past stock price movements and trading volumes to make predictions about where a stock's price might go next, without necessarily looking at the company's financial health.

Green Cross Corporation Technical Stock Analysis
# Analysis Recommendation
1 Awesome Oscillator Hold
2 MACD Buy
3 RSI Hold
4 Stoch RSI Sell

Green Cross Corporation Price Chart

Financial Statements

Financial statements are like report cards for companies. They show how much money a company makes (income statement), what it owns and owes (balance sheet), and where it spends its money (cash flow statement), helping stock investors understand if a company is healthy and worth investing in.

Income Statements

An income statement for a company is like a scoreboard for its profits and losses. It shows how much money the company made (revenue) and how much it spent to make that money (expenses), helping stock investors see if a company is making a profit or not.

Revenue in stock investing is the total amount of money a company earns from its sales, and it's a key factor that investors consider to assess a company's financial performance and growth potential.

Green Cross Corporation Revenue
Year Revenue Growth
2007 442.299.046.000
2008 516.096.685.000 14.3%
2009 643.208.349.000 19.76%
2010 791.015.317.000 18.69%
2011 767.911.770.550 -3.01%
2012 811.774.313.000 5.4%
2013 888.168.207.110 8.6%
2014 975.327.105.730 8.94%
2015 1.047.812.247.330 6.92%
2016 1.197.903.918.400 12.53%
2017 1.287.916.286.220 6.99%
2018 1.334.877.810.110 3.52%
2019 1.369.709.726.800 2.54%
2020 1.504.115.278.650 8.94%
2021 1.537.825.750.250 2.19%
2022 1.711.312.739.530 10.14%
2023 1.757.400.176.000 2.62%

Research and Development Expenses are the costs a company incurs to create and improve its products or services, which can be important for investors to evaluate a company's innovation and potential for future growth.

Green Cross Corporation Research and Development Expenses
Year Research and Development Expenses Growth
2007 27.158.498.000
2008 34.430.152.000 21.12%
2009 44.832.764.000 23.2%
2010 56.851.470.000 21.14%
2011 60.158.000.000 5.5%
2012 70.952.000.000 15.21%
2013 73.615.000.000 3.62%
2014 76.990.000.000 4.38%
2015 98.210.000.000 21.61%
2016 112.283.000.000 12.53%
2017 108.639.000.000 -3.35%
2018 122.029.000.000 10.97%
2019 126.673.000.000 3.67%
2020 137.987.000.000 8.2%
2021 146.030.000.000 5.51%
2022 191.347.000.000 23.68%
2023 0 0%

General and Administrative Expenses are the costs a company incurs to run its day-to-day operations, such as office rent, salaries, and utilities, which investors consider to understand a company's overall efficiency and management effectiveness.

Green Cross Corporation General and Administrative Expenses
Year General and Administrative Expenses Growth
2007 14.725.752.000
2008 20.017.327.000 26.43%
2009 24.837.979.000 19.41%
2010 21.330.002.000 -16.45%
2011 23.837.534.000 10.52%
2012 26.788.896.000 11.02%
2013 28.464.352.000 5.89%
2014 32.106.659.000 11.34%
2015 37.513.413.000 14.41%
2016 39.449.761.000 4.91%
2017 40.319.081.000 2.16%
2018 40.780.976.000 1.13%
2019 41.629.768.000 2.04%
2020 39.236.084.000 -6.1%
2021 39.251.651.000 0.04%
2022 44.296.797.000 11.39%
2023 432.393.188.000 89.76%

EBITDA stands for Earnings Before Interest, Taxes, Depreciation, and Amortization. It is a measure that helps stock investors analyze a company's profitability by looking at its earnings without considering certain expenses. This helps to get a clearer picture of the company's financial performance and its ability to generate cash flow.

Green Cross Corporation EBITDA
Year EBITDA Growth
2007 64.410.803.000
2008 52.346.688.000 -23.05%
2009 136.168.441.000 61.56%
2010 160.943.472.000 15.39%
2011 102.849.966.680 -56.48%
2012 90.412.418.050 -13.76%
2013 94.953.976.550 4.78%
2014 146.261.442.850 35.08%
2015 164.717.663.790 11.2%
2016 116.512.708.430 -41.37%
2017 114.413.681.430 -1.83%
2018 89.823.501.200 -27.38%
2019 79.856.165.220 -12.48%
2020 84.688.502.640 5.71%
2021 232.311.285.900 63.55%
2022 173.338.550.930 -34.02%
2023 563.410.908.000 69.23%

Gross profit is the money a company makes from selling its products or services after subtracting the cost of producing or providing them, and it is an important measure for investors to understand a company's profitability.

Green Cross Corporation Gross Profit
Year Gross Profit Growth
2007 180.404.313.000
2008 204.242.610.000 11.67%
2009 269.746.934.000 24.28%
2010 314.691.088.000 14.28%
2011 258.855.675.190 -21.57%
2012 253.579.578.410 -2.08%
2013 274.893.816.400 7.75%
2014 310.499.554.970 11.47%
2015 338.996.683.620 8.41%
2016 352.078.337.600 3.72%
2017 366.803.858.680 4.01%
2018 345.867.683.880 -6.05%
2019 372.315.307.690 7.1%
2020 440.626.609.400 15.5%
2021 520.593.271.950 15.36%
2022 581.804.463.260 10.52%
2023 563.410.908.000 -3.26%

Net income in stock investing is like the money a company actually gets to keep as profit after paying all its bills, and it's an important measure to understand how well a company is doing financially.

Green Cross Corporation Net Profit
Year Net Profit Growth
2007 44.357.145.000
2008 48.872.734.000 9.24%
2009 80.524.433.000 39.31%
2010 104.688.642.000 23.08%
2011 55.367.168.000 -89.08%
2012 53.643.053.420 -3.21%
2013 70.066.278.510 23.44%
2014 83.944.674.440 16.53%
2015 94.967.401.930 11.61%
2016 62.969.546.580 -50.81%
2017 53.246.604.740 -18.26%
2018 34.429.474.380 -54.65%
2019 -11.287.400.060 405.03%
2020 81.048.858.100 113.93%
2021 123.211.805.900 34.22%
2022 65.453.133.850 -88.24%
2023 55.687.068.000 -17.54%

EPS, or earnings per share, is a measure that shows how much profit a company has earned for each outstanding share of its stock, and it is important for stock investors as it helps understand the profitability of a company and compare it with other companies in the market.

Green Cross Corporation Earning per Share (EPS)
Year Earning per Share (EPS) Growth
2007 4.630
2008 5.075 8.77%
2009 8.286 38.75%
2010 10.581 21.68%
2011 5.171 -104.64%
2012 4.948 -4.51%
2013 6.140 19.43%
2014 7.260 15.43%
2015 8.213 11.6%
2016 5.451 -50.67%
2017 4.665 -16.85%
2018 3.017 -54.62%
2019 -990 405.06%
2020 7.101 113.93%
2021 10.796 34.23%
2022 5.735 -88.25%
2023 4.879 -17.54%

Cashflow Statements

Cashflow statements show the movement of money in and out of a company, helping stock investors understand how much money a company makes and spends. By examining cashflow statements, investors can assess if a company is generating enough cash to pay its bills, invest in growth, and provide returns to stockholders.

Free cash flow is the leftover cash that a company generates after covering its operating expenses and capital expenditures, which is important for stock investors as it shows how much money a company has available to invest in growth, pay dividends, or reduce debt.

Green Cross Corporation Free Cashflow
Year Free Cashflow Growth
2007 -39.212.635.000
2008 -84.177.848.000 53.42%
2009 92.317.206.000 191.18%
2010 56.741.213.000 -62.7%
2011 -169.230.790 33628.89%
2012 -22.695.816.480 99.25%
2013 -60.951.692.040 62.76%
2014 -13.956.372.620 -336.73%
2015 -90.394.415.280 84.56%
2016 -100.409.045.720 9.97%
2017 2.309.081.460 4448.44%
2018 -50.626.194.060 104.56%
2019 -107.325.776.910 52.83%
2020 -65.421.558.150 -64.05%
2021 2.440.256.800 2780.93%
2022 24.464.070.830 90.03%
2023 -34.371.541.440 171.18%

Operating cash flow represents the cash generated or consumed by a company's day-to-day operations, excluding external investing or financing activities, and is crucial for stock investors as it shows how much cash a company is generating from its core business operations.

Green Cross Corporation Operating Cashflow
Year Operating Cashflow Growth
2007 35.223.947.000
2008 -20.729.139.000 269.92%
2009 112.006.156.000 118.51%
2010 84.471.459.000 -32.6%
2011 54.855.488.030 -53.99%
2012 50.756.715.570 -8.08%
2013 29.689.475.480 -70.96%
2014 56.763.005.920 47.7%
2015 45.243.777.660 -25.46%
2016 -1.742.284.530 2696.81%
2017 57.879.006.000 103.01%
2018 14.410.216.140 -301.65%
2019 40.291.382.030 64.23%
2020 35.973.500.910 -12%
2021 125.978.948.880 71.44%
2022 119.154.310.880 -5.73%
2023 -11.957.008.270 1096.52%

Capex, short for capital expenditures, refers to the money a company spends on acquiring or upgrading tangible assets like buildings, equipment, or technology, which is important for stock investors as it indicates how much a company is investing in its infrastructure to support future growth and profitability.

Green Cross Corporation Capital Expenditure
Year Capital Expenditure Growth
2007 74.436.582.000
2008 63.448.709.000 -17.32%
2009 19.688.950.000 -222.26%
2010 27.730.246.000 29%
2011 55.024.718.820 49.6%
2012 73.452.532.050 25.09%
2013 90.641.167.520 18.96%
2014 70.719.378.540 -28.17%
2015 135.638.192.940 47.86%
2016 98.666.761.190 -37.47%
2017 55.569.924.540 -77.55%
2018 65.036.410.200 14.56%
2019 147.617.158.940 55.94%
2020 101.395.059.060 -45.59%
2021 123.538.692.080 17.92%
2022 94.690.240.050 -30.47%
2023 22.414.533.170 -322.45%

Balance Sheet

Balance sheets provide a snapshot of a company's financial health and its assets (such as cash, inventory, and property) and liabilities (like debts and obligations) at a specific point in time. For stock investors, balance sheets help assess the company's overall worth and evaluate its ability to meet financial obligations and support future growth.

Equity refers to the ownership interest or stake that shareholders have in a company, representing their claim on its assets and earnings after all debts and liabilities are paid.

Green Cross Corporation Equity
Year Equity Growth
2007 236.000.801.000
2008 267.176.776.000 11.67%
2009 358.823.252.000 25.54%
2010 538.489.310.000 33.36%
2011 618.149.481.780 12.89%
2012 671.829.360.380 7.99%
2013 823.101.200.770 18.38%
2014 892.661.536.850 7.79%
2015 956.809.486.510 6.7%
2016 993.071.347.230 3.65%
2017 1.040.213.175.990 4.53%
2018 1.126.206.777.350 7.64%
2019 1.184.076.724.830 4.89%
2020 1.269.305.743.500 6.71%
2021 1.499.757.017.640 15.37%
2022 1.566.641.931.080 4.27%
2023 1.552.042.856.000 -0.94%

Assets represent the valuable resources that a company owns, such as cash, inventory, property, and equipment, and understanding a company's assets helps investors assess its value and potential for generating future profits.

Green Cross Corporation Assets
Year Assets Growth
2007 425.630.634.000
2008 549.371.034.000 22.52%
2009 713.027.568.000 22.95%
2010 741.299.765.000 3.81%
2011 860.353.832.430 13.84%
2012 954.379.519.530 9.85%
2013 1.104.264.800.880 13.57%
2014 1.330.351.374.210 16.99%
2015 1.415.128.445.570 5.99%
2016 1.550.614.664.030 8.74%
2017 1.703.581.525.060 8.98%
2018 1.723.409.866.450 1.15%
2019 1.959.299.527.600 12.04%
2020 2.151.399.593.550 8.93%
2021 2.462.144.732.200 12.62%
2022 2.525.537.081.260 2.51%
2023 2.677.751.935.000 5.68%

Liabilities refer to the financial obligations or debts that a company owes to creditors or external parties, and understanding a company's liabilities is important for investors as it helps assess the company's financial risk and ability to meet its obligations.

Green Cross Corporation Liabilities
Year Liabilities Growth
2007 189.629.833.000
2008 282.194.258.000 32.8%
2009 354.204.316.000 20.33%
2010 199.065.365.000 -77.93%
2011 230.072.793.880 13.48%
2012 269.146.206.440 14.52%
2013 264.856.231.500 -1.62%
2014 409.724.547.430 35.36%
2015 417.424.433.120 1.84%
2016 491.603.629.980 15.09%
2017 594.868.624.410 17.36%
2018 597.203.089.100 0.39%
2019 775.222.802.770 22.96%
2020 882.093.850.050 12.12%
2021 962.387.714.560 8.34%
2022 958.895.150.180 -0.36%
2023 1.125.709.079.000 14.82%

Green Cross Corporation Financial Ratio (TTM)

Valuation Metrics

Revenue per Share
143118.57
Net Income per Share
-649.65
Price to Earning Ratio
-176.25x
Price To Sales Ratio
0.8x
POCF Ratio
26.15
PFCF Ratio
-18
Price to Book Ratio
1
EV to Sales
0.8
EV Over EBITDA
5.16
EV to Operating CashFlow
26.16
EV to FreeCashFlow
-18
Earnings Yield
-0.01
FreeCashFlow Yield
-0.06
Market Cap
1.306,80 Bil.
Enterprise Value
1.306,80 Bil.
Graham Number
40974.92
Graham NetNet
-98648.45

Income Statement Metrics

Net Income per Share
-649.65
Income Quality
2.37
ROE
-0.01
Return On Assets
-0.01
Return On Capital Employed
0.01
Net Income per EBT
0.89
EBT Per Ebit
-1.59
Ebit per Revenue
0.01
Effective Tax Rate
0.27

Margins

Sales, General, & Administrative to Revenue
0.22
Research & Developement to Revenue
0.09
Stock Based Compensation to Revenue
0
Gross Profit Margin
0.48
Operating Profit Margin
0.01
Pretax Profit Margin
-0.02
Net Profit Margin
-0.01

Dividends

Dividend Yield
0.02
Dividend Yield %
1.53
Payout Ratio
-3.35
Dividend Per Share
1750

Operating Metrics

Operating Cashflow per Share
4378.05
Free CashFlow per Share
-6361.34
Capex to Operating CashFlow
-2.45
Capex to Revenue
-0.08
Capex to Depreciation
-1.74
Return on Invested Capital
0
Return on Tangible Assets
-0
Days Sales Outstanding
0
Days Payables Outstanding
0
Days of Inventory on Hand
0
Receivables Turnover
0
Payables Turnover
0
Inventory Turnover
0
Capex per Share
-10739.39

Balance Sheet

Cash per Share
0,00
Book Value per Share
114.860,67
Tangible Book Value per Share
136009.04
Shareholders Equity per Share
114860.67
Interest Debt per Share
1705.97
Debt to Equity
0
Debt to Assets
0
Net Debt to EBITDA
0
Current Ratio
1.28
Tangible Asset Value
1.552,04 Bil.
Net Current Asset Value
-0,11 Bil.
Invested Capital
0
Working Capital
247,93 Bil.
Intangibles to Total Assets
0
Average Receivables
219,90 Bil.
Average Payables
74,49 Bil.
Average Inventory
254167834210
Debt to Market Cap
0

Dividends

Dividends in stock investing are like rewards that companies give to their shareholders. They are a portion of the company's profits distributed to investors, typically in the form of cash payments, as a way for them to share in the company's success.

Green Cross Corporation Dividends
Year Dividends Growth
2006 689
2007 919 25.05%
2008 919 0%
2009 1.148 20.03%
2010 1.632 29.66%
2011 1.399 -16.65%
2012 1.166 -20.09%
2013 1.250 6.8%
2014 1.250 0%
2015 1.750 28.57%
2016 1.250 -40%
2017 1.250 0%
2018 1.000 -25%
2019 1.000 0%
2020 1.500 33.33%
2021 2.000 25%
2022 1.750 -14.29%

Green Cross Corporation Profile

About Green Cross Corporation

Green Cross Corporation, a biopharmaceutical company, develops drugs and vaccines in South Korea. The company provides plasma derivatives, including albumin, immunoglobulin, and antithrombin; and vaccines for hepatitis-B, Hantavirus hemorrhagic fever, influenza, flu, and varicella. It also offers prescription drugs for the bleeding symptom control and hemostasis for persons with hemophilia A; prevention and treatment of bleeding episodes induced by hemophilia A and post-operative treatment; and treatment of neutropenia, hunter syndrome, and liver cancer, as well as treatment of anti-inflammation, pain relief, and osteoarthritis. In addition, the company provides over the counter drugs. It also exports its products to approximately 50 countries. The company has a licensing and collaboration agreement with Tottori University for development of GM1 gangliosidosis chaperone therapy. The company was formerly known as Sudo Microorganism Medical Supplies Company and changed its name to Green Cross Corporation in 1971. Green Cross Corporation was founded in 1967 and is headquartered in Yongin-si, South Korea. Green Cross Corporation is a subsidiary of Green Cross Holdings Corporation.

CEO
Mr. Il-Sup Huh Ph.D.
Employee
2.098
Address
107, Ihyeon-ro 30beon-gil
Yongin-Si,

Green Cross Corporation Executives & BODs

Green Cross Corporation Executives & BODs
# Name Age
1 Mr. Eun-Cheol Hur
President & Director
70
2 Mr. Young Sup Huh
Executive Vice President
70
3 Mr. In-Jae Lee
Senior MD & Director
70
4 Mr. Byeong-Hwa Kim
Vice President & Director
70
5 Mr. Il-Sup Huh Ph.D.
Chairman & Chief Executive Officer
70
6 Mr. Min-Taek Lee
Senior Managing Director of Sales
70

Green Cross Corporation Competitors

Yuhan Corporation Logo
Yuhan Corporation

000100.KS

(2.5)
Hanmi Pharm. Co., Ltd. Logo
Hanmi Pharm. Co., Ltd.

128940.KS

(1.0)
Celltrion, Inc. Logo
Celltrion, Inc.

068270.KS

(2.0)
Nongshim Co., Ltd. Logo
Nongshim Co., Ltd.

004370.KS

(3.0)